This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG7U0AF_L.jpg
The offer values the California-based biopharmaceutical company at $2.6 billion, including the $473 million Nestle had already invested in Aimmune, Nestle said in a statement.
